Catalyst MedTech has announced a strategic partnership with APQ Health to enhance access to advanced cardiac CT angiography (CCTA) visualization and plaque analysis services. This collaboration aims to address the growing demand for early detection and personalized risk assessment in coronary artery disease management.
The partnership comes at a time when healthcare providers are increasingly adopting cardiac CT as a primary diagnostic tool for chest pain. However, many face challenges such as limited access to specialized software and complex workflows, which hinder the broader implementation of advanced plaque analysis. Catalyst MedTech plans to integrate APQ Health’s coronary CTA viewer software and Autoplaque® analysis services, streamlining workflows to improve clinical utilization.
Healthcare providers will benefit from on-premises CCTA visualization tools and optional remote plaque analysis services, facilitating rapid turnaround times and supporting physician documentation and reimbursement pathways. This solution is adaptable to various existing systems, offering a flexible pathway for organizations to implement advanced cardiac CT analysis.
This partnership not only enhances technical capabilities but also aims to alleviate operational burdens on clinical teams, making it easier for healthcare providers to incorporate advanced imaging into routine practice. As Martin Shirley, President & CEO of Catalyst MedTech, noted, this collaboration extends beyond imaging to include advanced quantitative analysis, ultimately improving patient care in cardiovascular diagnostics.